a company, which engages in the provision of clinical stage biotechnology company
Industry Biotechnology
A.I.dvisor tells us that XCUR and VSTM have been poorly correlated (+28% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that XCUR and VSTM's prices will move in lockstep.
Ticker / NAME | Correlation To XCUR | 1D Price Change % | ||
---|---|---|---|---|
XCUR | 100% | -1.44% | ||
VSTM - XCUR | 28% Poorly correlated | -3.20% | ||
NBY - XCUR | 25% Poorly correlated | -0.43% | ||
ERNA - XCUR | 23% Poorly correlated | -6.60% | ||
SNSE - XCUR | 22% Poorly correlated | -0.97% | ||
ARCT - XCUR | 22% Poorly correlated | -8.10% | ||
More |